{"gene":"SLC23A2","run_date":"2026-06-10T07:46:32","timeline":{"discoveries":[{"year":1999,"finding":"Human SVCT2 (hSVCT2) encodes a 650 amino acid, ~70 kDa protein that mediates sodium-dependent, saturable transport of ascorbic acid with a Km of 69 µM and a Na⁺:ascorbate stoichiometry of 2:1, establishing it as a secondary active transporter.","method":"Functional expression of hSVCT2 cDNA in mammalian cells; radiolabeled ascorbate uptake assays; Na⁺ activation kinetics","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct reconstitution via cDNA expression, saturation kinetics, and Na⁺ stoichiometry established in a dedicated cloning/characterization paper","pmids":["10471399"],"is_preprint":false},{"year":2005,"finding":"In polarized epithelial cells (Caco-2 and MDCK), SVCT2-EGFP localizes predominantly to the basolateral membrane, whereas SVCT1 localizes apically; basolateral SVCT2 function was confirmed by ascorbate uptake assays with basolateral membrane exposure. An N-terminal basolateral targeting sequence (BTS) conserved among mammalian SVCT2 forms is responsible for this sorting.","method":"EGFP-tagged SVCT constructs expressed in MDCK and Caco-2 cells; confocal microscopy; Transwell ascorbate transport assays; domain-swap and point-mutation analysis","journal":"Biochemical and biophysical research communications / Biochemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — replicated across two papers with confocal imaging, functional transport assays, and mutagenesis identifying the targeting sequence","pmids":["15993839","19216494"],"is_preprint":false},{"year":2000,"finding":"SVCT2 is expressed in cultured astrocytes (Northern blot) but in situ hybridization detects SVCT2 mRNA only in neurons and not in normal astrocytes in vivo, indicating that astrocyte SVCT2 expression is an artifact of culture conditions and that in the intact brain SVCT2 is neuron-specific.","method":"Northern blot analysis of cultured astrocytes; in situ hybridization on brain sections; quinolinic acid neurotoxin challenge model","journal":"Neuroreport","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal methods (Northern + ISH) in one study; however later work showed ischemia-induced astrocyte SVCT2 expression, qualifying the neuron-specificity claim to baseline conditions","pmids":["10841345"],"is_preprint":false},{"year":2000,"finding":"SVCT2-mediated Na⁺-ascorbate cotransport across the plasma membrane is the primary determinant of steady-state intracellular ascorbic acid concentration in primary astrocyte cultures; transport activity and intracellular ascorbate are modulated by cAMP, hyposmotic swelling, and extracellular Na⁺ and K⁺ levels.","method":"SVCT2 expression detected by Northern blot in rat brain and cultured astrocytes; mathematical modeling validated against experimental ascorbate uptake measurements under varying ionic and osmotic conditions","journal":"Brain research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Northern blot combined with functional transport assays and validated mathematical model; single lab","pmids":["11036152"],"is_preprint":false},{"year":2001,"finding":"SVCT2 (but not SVCT1) mediates Na⁺-dependent, saturable ascorbic acid uptake in human lens epithelial cells (HLE-B3); SVCT2 gene expression is upregulated by oxidant stress (tert-butylhydroperoxide), and uptake is partially modulated by cAMP, cytochalasin B, and phorbol ester signaling.","method":"RT-PCR for SVCT isoform identification; radiolabeled (¹⁴C) ascorbate uptake assays; inhibitor studies; gene expression analysis","journal":"Experimental eye research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RT-PCR plus functional uptake assays with pharmacological dissection; single lab","pmids":["11446766"],"is_preprint":false},{"year":2003,"finding":"SVCT2 null mice show severely reduced ascorbic acid in fetal cortex, placenta, and lung (but not liver, the site of synthesis); adrenal medullary catecholamine synthesis is impaired—norepinephrine decreased 50%, epinephrine 81%—with depletion of chromaffin cell secretory vesicles and increased apoptosis, establishing SVCT2 as essential for ascorbate-dependent dopamine β-hydroxylase activity in the adrenal medulla.","method":"SVCT2 knockout mouse model; HPLC catecholamine measurements; electron microscopy of chromaffin cells; plasma corticosterone assay","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with multiple orthogonal readouts (biochemical, ultrastructural, endocrine), replicated across tissues","pmids":["12897061"],"is_preprint":false},{"year":2003,"finding":"Focal cerebral ischemia (middle cerebral artery occlusion) upregulates SVCT2 mRNA in both neurons and astrocytes in the peri-infarct zone, providing in situ evidence for SVCT2 expression in reactive astrocytes—the first demonstration of astrocytic SVCT2 in situ.","method":"In situ hybridization on rat brain sections 2 h and 22 h after MCAO","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ISH with temporal controls in a defined injury model; single lab, single method","pmids":["12887688"],"is_preprint":false},{"year":2005,"finding":"SVCT2 is highly expressed in the apical membranes of hypothalamic tanycytes (specialized ependymal/glial cells) and mediates high-affinity ascorbic acid uptake in these cells, providing the mechanism by which ascorbate is concentrated in the hypothalamic region.","method":"In situ hybridization; ultrastructural immunocytochemistry; primary tanycyte cultures with functional ascorbate uptake assays","journal":"Glia","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (ISH, immunoEM, functional uptake in primary cultures) in a single study","pmids":["15625716"],"is_preprint":false},{"year":2005,"finding":"SVCT2 is the sole active transporter for ascorbic acid in primary human chondrocytes; siRNA knockdown of SVCT2 abolishes the active (Na⁺-dependent, saturable, concentrative) component of ascorbate transport, and these cells can concentrate ascorbate ~960-fold over extracellular levels.","method":"Radiolabeled ascorbate uptake assays; RT-PCR isoform identification; siRNA knockdown of SVCT2","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — siRNA knockdown with functional rescue readout combined with kinetic characterization; clean loss-of-function with specific phenotype","pmids":["15921655"],"is_preprint":false},{"year":2006,"finding":"SVCT2 expression in anucleated human platelets is regulated at the translational level; platelets compensate for fluctuations in ascorbate levels by modulating SVCT2 protein expression post-transcriptionally, and SVCT2 upregulation occurs during platelet activation accompanied by vitamin C depletion.","method":"Western blot and functional ascorbate uptake in isolated anucleated platelets; platelet activation assays","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — use of anucleated cells provides direct evidence for translational control; single lab with two orthogonal approaches (protein expression + functional transport)","pmids":["17291984"],"is_preprint":false},{"year":2007,"finding":"SVCT2 transcription in C2C12 myotubes is redox-regulated: H₂O₂ upregulates SVCT2 gene expression and lipoate (antioxidant) downregulates it, with the effect mediated through AP-1 and NF-κB signaling pathways.","method":"SVCT2 mRNA quantification in C2C12 myotubes treated with H₂O₂ or lipoate; pharmacological inhibition of AP-1/NF-κB","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — mRNA-level readouts with pathway inhibitors; single lab, multiple consistent treatments","pmids":["17643393"],"is_preprint":false},{"year":2008,"finding":"SVCT2 is expressed and functional in rat brainstem cells, cortical neurons, cerebellar neurons, and neuroblastoma cells; the transporter displays two kinetically distinct affinity components for ascorbate, and flavonoids (notably quercetin) dose-dependently inhibit SVCT2-mediated ascorbate transport.","method":"RT-PCR; immunohistochemistry/ISH in fetal and adult rat brain; radiolabeled ascorbate uptake kinetics; dose-response inhibition with flavonoids","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cell types characterized with functional assays; single lab, orthogonal methods","pmids":["19054284"],"is_preprint":false},{"year":2009,"finding":"PMA-induced monocyte-to-macrophage differentiation markedly increases SVCT2 mRNA, protein, and transport function through a pathway requiring sustained activation of PKCβI/II → MEK/ERK (MAP kinase), with additional contributions from NADPH oxidase, NF-κB, and both known SVCT2 promoters.","method":"THP-1 monocyte differentiation model; SVCT2 mRNA/protein quantification; pharmacological inhibition of PKC isoforms (isoform-selective inhibitors), MEK/ERK, NF-κB, NADPH oxidase; promoter reporter assays","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal inhibitor approaches defining a specific signaling cascade, combined with promoter analysis; single lab but rigorous multi-method design","pmids":["19232538"],"is_preprint":false},{"year":2009,"finding":"SVCT2 in epithelial cells contains a hierarchically dominant N-terminal basolateral targeting sequence (BTS) and a C-terminal sequence required for plasma membrane incorporation and retention; deletion of the BTS redirects SVCT2 to the apical membrane, and C-terminal deletion results in intracellular accumulation regardless of the BTS.","method":"Domain-swap, deletion, insertion, and point-mutation of EGFP-tagged SVCT1/SVCT2 constructs stably expressed in MDCK cells; confocal microscopy; Transwell ascorbate transport assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — structure-function mutagenesis with functional validation across multiple constructs; defines molecular determinants of polarized sorting","pmids":["19216494"],"is_preprint":false},{"year":2010,"finding":"SVCT2 null mice exhibit reduced vitamin C levels in fetal placenta and cortex (but not liver), elevated oxidative stress markers (malondialdehyde, isoketals, F₂-isoprostanes, F₄-neuroprostanes), cortical and brainstem hemorrhage, increased apoptosis, and basement membrane disruption, establishing that SVCT2 is critical for maintaining fetal vitamin C levels and survival.","method":"SVCT2 knockout mouse model; HPLC ascorbate measurements; lipid peroxidation biomarkers; immunohistochemistry for apoptosis and basement membrane proteins","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — whole-animal KO with genotype-dependent ascorbate levels and multiple oxidative stress biomarkers across tissues","pmids":["20541602"],"is_preprint":false},{"year":2010,"finding":"SVCT2 is the primary mediator of ascorbic acid uptake into Schwann cells; siRNA-mediated knockdown and phloretin inhibition significantly reduce ¹⁴C-ascorbate uptake, and SVCT2 is localized to uncompacted myelin compartments of Schwann cells, with transport activity dependent on extracellular Na⁺, Mg²⁺, and Ca²⁺.","method":"Immunohistochemistry, immunoblotting, RT-PCR in peripheral nerve and Schwann cell cultures; ¹⁴C-ascorbate uptake assays; siRNA knockdown; phloretin inhibition; ex vivo uptake in sciatic nerve","journal":"Glia","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA KD with functional readout plus pharmacological inhibition and ex vivo validation; multiple orthogonal methods","pmids":["19672970"],"is_preprint":false},{"year":2010,"finding":"Ascorbic acid depletion in SMP30/GNL knockout mouse hepatocytes enhances SVCT2 (and SVCT1) mRNA expression and increases ascorbate uptake, demonstrating that intracellular ascorbic acid negatively regulates SVCT2 expression in the liver.","method":"SMP30/GNL KO mouse model (ascorbate synthesis-deficient); SVCT mRNA quantification in tissues; primary hepatocyte culture ascorbate uptake assays","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic model with functional uptake confirmation in primary cells; single lab","pmids":["20122894"],"is_preprint":false},{"year":2011,"finding":"The SVCT2 exon 1b promoter (CpG-rich, ubiquitously expressed) is regulated by a functional initiator that binds YY1, which cooperates with upstream Sp1/Sp3 elements; YY1/Sp1 and YY1/Sp3 complexes synergistically activate the exon 1b promoter, and EGR-1, EGR-2, WT1, and MAZ differentially regulate activity through overlapping GC-box elements.","method":"Promoter deletion constructs; EMSA with YY1/Sp antibody supershifts; co-transfection reporter assays in multiple cell lines","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA and reporter assays; single lab but multiple constructs and transcription factors tested","pmids":["21335086"],"is_preprint":false},{"year":2011,"finding":"Cell-specific transcription from the CpG-poor SVCT2 exon 1a promoter is controlled by cooperative binding of NF-Y and USF to Y-box and E-box elements; CpG methylation at the upstream USF-binding site impairs both USF binding and NF-Y/USF complex formation, silencing exon 1a transcription in a cell-type-specific manner.","method":"Promoter deletion/mutation constructs; EMSA with antibody supershifts; bisulfite methylation analysis; decitabine demethylation experiments; co-transfection reporter assays","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — mutagenesis, EMSA, methylation analysis, and pharmacological demethylation all converge on the same CpG-site mechanism","pmids":["21770893"],"is_preprint":false},{"year":2012,"finding":"SVCT2 is expressed in bone marrow stromal cells (BMSCs) as the sole ascorbate transporter; SVCT2 expression is upregulated during osteogenic differentiation (maximal at earliest phase), and lentiviral shRNA knockdown of SVCT2 inhibits osteogenesis; redox status positively (oxidant Sin-1) or negatively (ascorbic acid) modulates SVCT2 expression in BMSCs.","method":"RT-PCR; ¹⁴C-ascorbate uptake assays (Na⁺-dependent, saturable); lentiviral shRNA KD of SVCT2; osteogenic differentiation assays; redox treatments","journal":"Stem cell research","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function with defined osteogenic phenotype, kinetic transport characterization, and redox regulation; multiple methods","pmids":["23089627"],"is_preprint":false},{"year":2012,"finding":"Doxorubicin reduces SVCT2 expression and localization at the sarcolemma of cardiomyocytes; vitamin C supplementation blunts this reduction, suggesting that SVCT2 downregulation contributes to doxorubicin-induced cardiotoxicity by impairing ascorbate uptake.","method":"Isolated rat cardiomyocytes; Western blot and immunofluorescence localization of SVCT2; oxidative stress and apoptosis markers","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — protein expression and localization data with pharmacological intervention; single lab, no genetic KD confirmation","pmids":["22763122"],"is_preprint":false},{"year":2012,"finding":"SVCT2 transgenic mice (global SVCT2 overexpression) show increased SVCT2 mRNA and correspondingly increased ascorbic acid levels in all organs except liver; this elevated ascorbate protects against paraquat-induced oxidative stress in lung (reduced F₂-isoprostanes).","method":"SVCT2 transgenic mouse model; qRT-PCR; HPLC ascorbate measurements; F₂-isoprostane oxidative stress markers; paraquat oxidative challenge","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic gain-of-function model with biochemical readouts; single lab","pmids":["22558179"],"is_preprint":false},{"year":2013,"finding":"SVCT2 knockdown in BMSCs decreases cell attachment, spreading, trans-well migration, and wound healing; supplementation with vitamin C rescues these defects in wild-type but not SVCT2-knockdown cells; SVCT2 KD and oxidative stress alter cytoskeletal (F-actin) dynamics and activate p38 MAPK phosphorylation, which is inhibited by vitamin C.","method":"Lentiviral shRNA SVCT2 knockdown in BMSCs; cell adhesion, trans-well migration, and scratch wound assays; F-actin staining; p38 MAPK phosphorylation Western blot","journal":"Stem cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with multiple functional phenotypic readouts and signaling pathway analysis; single lab","pmids":["24365600"],"is_preprint":false},{"year":2013,"finding":"SLC23A2/SVCT2 does not mediate ascorbic acid efflux (release) in renal proximal tubular epithelial cells; SLC23A2 is not expressed in the human proximal tubule, and a Xenopus oocyte dual-transporter system confirmed that SLC23A1 also does not mediate basolateral ascorbate release, indicating the efflux mechanism remains unidentified.","method":"Xenopus laevis oocyte expression system (dual-transporter assay); mammalian cell overexpression; human tissue gene expression analysis","journal":"Physiological reports","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — reconstitution in Xenopus oocytes is rigorous; finding is a defined NEGATIVE result for efflux function of SLC23A2","pmids":["24400138"],"is_preprint":false},{"year":2014,"finding":"SVCT2 overexpression in N2a neuroblastoma cells induces increased MAP2+ neurites and filopodia formation; SVCT2 overexpression combined with ascorbate treatment promotes ERK1/2 phosphorylation, linking SVCT2-mediated ascorbate uptake to ERK signaling during neuronal branching.","method":"Lentiviral SVCT2-EYFP overexpression in N2a cells; immunofluorescence for MAP2 and filopodia; Western blot for ERK1/2 phosphorylation","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — gain-of-function with defined morphological and signaling readouts; single lab, two methods","pmids":["26646539"],"is_preprint":false},{"year":2014,"finding":"A short isoform of SVCT2 (SVCT2sh) interacts physically with full-length SVCT2 (SVCT2wt), as shown by FRET, and co-expression of SVCT2sh inhibits ascorbate uptake by SVCT2wt in N2a cells, indicating that the short isoform acts as a dominant-negative regulator of transporter function.","method":"FRET analysis of co-expressed SVCT2wt and SVCT2sh in N2a cells; ¹⁴C-ascorbate uptake assays","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRET for protein-protein interaction and functional transport assay; single lab, two orthogonal methods","pmids":["24947427"],"is_preprint":false},{"year":2015,"finding":"miR-141 and miR-200a directly repress SVCT2 expression by targeting the 3'-UTR of SVCT2 mRNA in BMSCs, reducing osteogenic differentiation; miRNA inhibitors restore SVCT2 expression and osteogenic gene expression.","method":"3'-UTR luciferase reporter assays; miRNA mimic and inhibitor transfections; SVCT2 protein quantification; osteogenic differentiation assays in mouse BMSCs","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — 3'-UTR reporter plus functional phenotype; single lab, two methods","pmids":["25617715"],"is_preprint":false},{"year":2016,"finding":"SVCT2 upregulation in response to ethanol-induced neuronal injury is mediated by activation of JNK and p38 MAPKs and the NF-κB pathway; miR-125a-5p negatively regulates SVCT2 protein expression and is downregulated during binge drinking, and miR-125a-5p overexpression reduces SVCT2 levels and intracellular ascorbate, increasing neuronal vulnerability.","method":"Rat binge-drinking model; primary cortical neurons with SVCT2 siRNA; SVCT2 mRNA/protein quantification; MAPK and NF-κB phosphorylation Western blots; miR-125a-5p overexpression","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro models with siRNA KD, signaling pathway analysis, and miRNA regulation; single lab","pmids":["27085842"],"is_preprint":false},{"year":2018,"finding":"Ascorbic acid increases SVCT2 levels at the plasma membrane via two distinct mechanisms: (1) an 'acute' response (~5–10 min) dependent on endocytic recycling (blocked by dominant-negative dynamin II, AP180, and Rab11); and (2) a 'post-acute' response (~30–60 min) dependent on SVCT2 trafficking from early secretory compartments (ER/Golgi), blocked by tunicamycin and brefeldin A and accelerated by the RUSH secretory system.","method":"RUSH system for synchronized ER-to-PM cargo trafficking; dominant-negative dynamin II, AP180, and Rab11 constructs; tunicamycin/brefeldin A treatment; surface biotinylation and ascorbate uptake assays","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal approaches including RUSH system, dominant-negative constructs, and pharmacological tools define two mechanistically distinct trafficking routes","pmids":["29545069"],"is_preprint":false},{"year":2019,"finding":"SVCT2 promotes migration of neural stem/progenitor cells (NSPCs) from the subventricular zone toward ischemic lesions by upregulating CDC42, which promotes F-actin assembly; SVCT2 overexpression or ascorbate treatment increases NSPC migration in vivo and in vitro under oxygen-glucose deprivation.","method":"SVCT2 overexpression vectors in vivo and in vitro; OGD cell model; immunostaining for CDC42 and F-actin; NSPC migration counting in vivo","journal":"Frontiers in cellular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with defined cellular phenotype (migration) and mechanistic pathway (CDC42/F-actin); single lab","pmids":["31607868"],"is_preprint":false},{"year":2021,"finding":"SVCT2 is localized primarily in the cell membrane and endoplasmic reticulum (but not mitochondria) of cortical neurons; lentiviral SVCT2 overexpression increases neuronal branching and synaptic protein expression in primary cortical neurons, and this effect depends on vitamin C recycling between neurons and astrocytes (DHA produced by neurons is reduced back to ascorbate by glial GLUT1, and GLUT1 inhibition in glia abolishes branching both in vitro and in the cortex in situ).","method":"SVCT2 lentiviral overexpression; immunofluorescence colocalization with ER/mitochondrial markers; SVCT2+/- and SVCT2-Tg primary cultures; WZB117 GLUT1 inhibitor in vitro and in vivo; cortical neuron branching and synaptic protein quantification","journal":"Antioxidants (Basel, Switzerland)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function, genetic models (KO/Tg), and in vivo pharmacological inhibition with functional readouts; single lab","pmids":["34573045"],"is_preprint":false},{"year":2021,"finding":"p53 directly represses SVCT2 transcription by binding proximal (~-185 to -171 bp) and distal (~-1800 to -1787 bp) p53-responsive elements in the SVCT2 promoter; chromatin immunoprecipitation shows p53 recruits corepressor HDAC3, leading to deacetylation of histone Ac-H4 at the proximal promoter and transcriptional silencing.","method":"ChIP assays for p53 and HDAC3 binding and histone acetylation; promoter reporter deletion/mutation assays; p53 overexpression/knockdown","journal":"Molecular biology reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with defined epigenetic readout (Ac-H4 deacetylation) and promoter mutagenesis; single lab","pmids":["33580460"],"is_preprint":false},{"year":2021,"finding":"SVCT2 functions as a receptor-like transporter: upon ascorbate binding and transport, SVCT2 induces JAK2 phosphorylation; activated JAK2 then phosphorylates the SVCT2 C-terminus, recruiting and activating STAT2; JAK2 activation further promotes ascorbate functions via phosphorylation of PDK1, TET3, and histone H3 Tyr41.","method":"Co-immunoprecipitation of SVCT2–JAK2 interaction; phosphorylation assays; SVCT2 mutant constructs; JAK2 and STAT2 activation readouts","journal":"International journal of biological macromolecules","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Co-IP and phosphorylation assays reported from a single lab with limited methodological detail in the abstract; novel and not independently replicated","pmids":["33484802"],"is_preprint":false},{"year":2022,"finding":"SVCT2-mediated ascorbate uptake in the medial prefrontal cortex supports DNA hydroxymethylation reprogramming via TET dioxygenases; chronic stress reduces SVCT2 expression and ascorbate in the mPFC, causing depressive-like behaviors through reduced TET-dependent demethylation, particularly at the S100A4 gene promoter, which in turn impairs ErbB4–BDNF signaling.","method":"Chronic stress mouse model; SVCT2 expression quantification; ascorbate HPLC; transcriptome and methylome sequencing; TET inhibition; ErbB4/BDNF pathway analysis","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — combined transcriptome + methylation sequencing with mechanistic pathway validation; single lab","pmids":["36436457"],"is_preprint":false},{"year":2023,"finding":"SVCT2 is a novel sodium-dependent urate transporter in addition to its ascorbate transport function; cell-based assays in SVCT2-expressing mammalian cells demonstrated urate uptake, and ascorbate inhibits SVCT2-mediated urate transport with an IC₅₀ of ~36.59 µM, suggesting competitive transport at physiological ascorbate concentrations.","method":"SVCT2-expressing mammalian cell-based urate uptake assay; inhibition studies with ascorbate; confirmation in mouse Svct2","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based functional transport assay with defined kinetics; replicated in mouse ortholog; single lab","pmids":["37390985"],"is_preprint":false},{"year":2023,"finding":"Blue light irradiation specifically upregulates SVCT2 expression in melanoma cells via the NF-κB signaling pathway both in vitro and in vivo, increasing intracellular vitamin C and, together with Fe²⁺ generated by blue light, triggers ferroptosis.","method":"Blue light treatment of melanoma cells in vitro and mouse melanoma model in vivo; SVCT2 protein quantification; NF-κB inhibitor studies; ROS/ferroptosis markers","journal":"Biomaterials","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo evidence with defined signaling pathway (NF-κB); single lab, multiple methods","pmids":["37276798"],"is_preprint":false},{"year":2023,"finding":"UVB-induced ROS in human lens epithelial cells activates NF-κB signaling, which downregulates SVCT2 expression; reduced SVCT2 decreases ascorbate uptake, further increasing ROS and apoptosis; NF-κB or ROS inhibition restores SVCT2 and reduces apoptosis, defining an NF-κB/SVCT2/ascorbate regulatory axis.","method":"UVB treatment of HLECs; SVCT2 siRNA knockdown; NF-κB inhibitor (PDTC) and ROS inhibitor (NAC); ¹⁴C-ascorbate uptake assays; ROS, apoptosis, and Bcl-2/Bax quantification","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA KD with functional ascorbate uptake assay and pathway inhibitors; single lab","pmids":["37246402"],"is_preprint":false},{"year":2024,"finding":"In late radial glia (lRG) cells in early postnatal cortex, SVCT2 is apically polarized; decreased SVCT2 (SVCT2+/- transgenic) accelerates lRG differentiation into astrocytes, whereas elevated SVCT2 expression (SVCT2-Tg) or ascorbate treatment maintains lRG in an undifferentiated state; in vivo SVCT2 overexpression in lRG generates migratory neuronal-marker-positive cells. The GSK3-β/AKT/mTORC2/PDK1 pathway is active in brains with high SVCT2/ascorbate levels.","method":"SVCT2+/- and SVCT2-Tg primary cultures and in vivo cortex; adenovirus-eGFP lineage tracing; immunofluorescence; GSK3-β/AKT/mTORC2 Western blots","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic gain- and loss-of-function models with multiple readouts; single lab","pmids":["38180226"],"is_preprint":false},{"year":2025,"finding":"Estrogen receptor α (ERα) directly interacts with SVCT2 protein and stabilizes it; ERα knockdown reduces SVCT2 protein levels and ascorbate uptake. In ERα-deficient conditions, the E3 ubiquitin ligase XIAP ubiquitinates SVCT2 and targets it for proteasomal degradation; XIAP silencing rescues SVCT2 stability, defining an ERα–XIAP–SVCT2 regulatory axis.","method":"Co-immunoprecipitation of ERα–SVCT2; ERα and XIAP siRNA knockdown; proteasome inhibitor rescue; ¹⁴C-ascorbate uptake assays; ubiquitination assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for direct interaction, ubiquitination assay, and functional transport readout; single lab, multiple methods","pmids":["40731045"],"is_preprint":false},{"year":2025,"finding":"SVCT2 overexpression in microglia before disease onset in 5xFAD Alzheimer's mice triggers redox reprogramming, generates a hybrid neuroprotective microglial phenotype co-expressing homeostatic and disease-associated markers, reduces amyloid plaque burden, and prevents synaptic/memory deficits; post-disease SVCT2 overexpression rescues synaptic plasticity and memory via changes in microglial secretory pathways, despite no effect on existing amyloid burden.","method":"Microglial-targeted SVCT2 overexpression in 5xFAD mice; primary microglial cultures from SVCT2-het and Tg mice; amyloid plaque quantification; synaptic and memory behavioral assays; microglial morphology and mRNA profiling","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo gain-of-function with multiple orthogonal phenotypic readouts in genetic AD model; single lab","pmids":["40907096"],"is_preprint":false}],"current_model":"SLC23A2/SVCT2 is a plasma membrane sodium-ascorbate cotransporter (2 Na⁺:1 ascorbate stoichiometry, Km ~50–70 µM) that mediates the primary active, concentrative uptake of ascorbic acid into metabolically active cells including neurons, glia, adrenal chromaffin cells, chondrocytes, Schwann cells, and immune cells; it localizes to the basolateral membrane of epithelial cells via an N-terminal targeting sequence and to the apical membrane of radial glia and tanycytes, with plasma membrane levels dynamically regulated by ascorbate-driven trafficking through both the early secretory pathway and endocytic recycling compartments; its transcription is controlled by cooperative YY1/Sp and NF-Y/USF complexes (with CpG methylation at the USF site providing cell-specific silencing) and is repressed by p53/HDAC3 and induced by NF-κB, AP-1, PKCβ/ERK, and redox signals; beyond transport, SVCT2 acts as a receptor-like transporter that activates JAK2/STAT2 signaling upon ascorbate binding, and XIAP-mediated ubiquitination (antagonized by ERα interaction) controls its protein stability; it also transports urate in a manner competitively inhibited by ascorbate, and its activity is essential for adrenal catecholamine synthesis, neuronal differentiation, osteogenic differentiation of bone marrow stromal cells, and modulation of the microglial neuroinflammatory response."},"narrative":{"mechanistic_narrative":"SLC23A2 (SVCT2) is a plasma-membrane sodium-dependent ascorbate cotransporter that mediates the concentrative, secondary-active uptake of vitamin C into metabolically active cells, with a Km of ~69 µM and a 2:1 Na⁺:ascorbate stoichiometry [PMID:10471399]. It serves as the principal or sole active ascorbate transporter in diverse cell types including astrocytes [PMID:11036152], chondrocytes—which concentrate ascorbate ~960-fold [PMID:15921655]—Schwann cells [PMID:19672970], bone marrow stromal cells [PMID:23089627], and neurons [PMID:19054284], and concentrates ascorbate in specialized brain cells such as apically polarized hypothalamic tanycytes [PMID:15625716] and radial glia [PMID:38180226]. In polarized epithelia SVCT2 is sorted to the basolateral membrane through a hierarchically dominant N-terminal basolateral targeting sequence, with a C-terminal element required for plasma-membrane incorporation [PMID:15993839, PMID:19216494]. Surface levels are dynamically tuned by ascorbate itself through a fast endocytic-recycling route and a slower ER/Golgi secretory route [PMID:29545069]. Genetic loss of SVCT2 in mice depletes ascorbate in fetal cortex, placenta, and lung and is essential for life, impairing adrenal catecholamine synthesis via ascorbate-dependent dopamine β-hydroxylase and producing cortical hemorrhage and oxidative damage [PMID:12897061, PMID:20541602]. SVCT2 supports tissue-building programs including osteogenic differentiation of stromal cells [PMID:23089627], neuronal branching and synaptic protein expression [PMID:26646539, PMID:34573045], and neural progenitor migration via CDC42/F-actin [PMID:31607868]. Its transcription is governed by an exon 1b promoter driven by YY1 cooperating with Sp factors [PMID:21335086] and a cell-specific exon 1a promoter controlled by NF-Y/USF complexes silenced by CpG methylation at the USF site [PMID:21770893], with repression by p53/HDAC3 [PMID:33580460] and redox-driven induction through NF-κB, AP-1, and PKCβ/MEK-ERK signaling [PMID:17643393, PMID:19232538]. Protein stability is set by an ERα–XIAP axis in which XIAP-mediated ubiquitination targets SVCT2 for degradation unless antagonized by ERα binding [PMID:40731045]. Beyond ascorbate, SVCT2 also transports urate in a manner competitively inhibited by ascorbate [PMID:37390985].","teleology":[{"year":1999,"claim":"Establishing that hSVCT2 is itself a sodium-coupled ascorbate transporter defined the molecular identity and energetic basis of cellular vitamin C uptake.","evidence":"Functional expression of hSVCT2 cDNA in mammalian cells with radiolabeled ascorbate uptake and Na⁺ activation kinetics","pmids":["10471399"],"confidence":"High","gaps":["No structural model of the transporter","Substrate translocation mechanism not resolved at atomic level"]},{"year":2000,"claim":"Mapping SVCT2 expression in brain and demonstrating it sets steady-state intracellular ascorbate clarified which CNS cells depend on this transporter under baseline conditions.","evidence":"Northern blot, in situ hybridization, and functional uptake/mathematical modeling in neurons and cultured astrocytes","pmids":["10841345","11036152"],"confidence":"Medium","gaps":["In vivo astrocytic expression initially appeared culture-artifactual","Did not address injury-induced expression"]},{"year":2003,"claim":"Genetic knockout established that SVCT2 is physiologically essential, particularly for ascorbate-dependent adrenal catecholamine synthesis, moving it from a transporter to a required component of endocrine and developmental physiology.","evidence":"SVCT2 null mouse with HPLC catecholamine measurement, chromaffin cell ultrastructure, and tissue ascorbate quantification; MCAO ischemia ISH","pmids":["12897061","12887688"],"confidence":"High","gaps":["Mechanism linking ascorbate to dopamine β-hydroxylase activity inferred rather than directly assayed","Injury-induced astrocytic upregulation mechanism unresolved"]},{"year":2005,"claim":"Identification of the N-terminal basolateral targeting sequence answered how SVCT2 achieves polarized localization distinct from SVCT1.","evidence":"EGFP-tagged constructs with domain swaps and mutagenesis in MDCK/Caco-2 cells plus Transwell transport assays; tanycyte ISH/immunoEM/uptake","pmids":["15993839","19216494","15625716"],"confidence":"High","gaps":["Trafficking adaptors recognizing the BTS not identified","Apical localization in tanycytes/radial glia uses a different determinant not defined"]},{"year":2009,"claim":"Dissecting the dual exon 1a/1b promoters and the PKCβ→MEK/ERK induction cascade established how SVCT2 expression is cell-type-specifically and inducibly controlled.","evidence":"Promoter deletion/reporter assays, EMSA supershifts, bisulfite methylation/demethylation, and isoform-selective inhibitor studies in THP-1 and multiple cell lines","pmids":["19232538","21335086","21770893"],"confidence":"High","gaps":["Relative usage of the two promoters across tissues not quantified","Upstream signals selecting promoter usage incompletely mapped"]},{"year":2010,"claim":"Loss-of-function in primary cells and feedback by intracellular ascorbate showed SVCT2 is the dominant active uptake route and is homeostatically autoregulated.","evidence":"siRNA/shRNA knockdown and phloretin inhibition in Schwann cells and BMSCs; ascorbate-synthesis-deficient SMP30/GNL KO hepatocytes; KO mouse oxidative-stress biomarkers","pmids":["19672970","20122894","20541602"],"confidence":"High","gaps":["Molecular sensor coupling intracellular ascorbate to expression not identified","Tissue-specific feedback thresholds undefined"]},{"year":2012,"claim":"Linking SVCT2 to osteogenic differentiation and redox-modulated expression connected the transporter to stem cell fate decisions.","evidence":"Lentiviral shRNA knockdown with osteogenic differentiation assays, kinetic transport characterization, and redox treatments in BMSCs; SVCT2-Tg gain-of-function mice","pmids":["23089627","22558179","22763122"],"confidence":"Medium","gaps":["Direct ascorbate-dependent enzymatic step driving osteogenesis not pinpointed","Cardiomyocyte data lack genetic confirmation"]},{"year":2014,"claim":"Discovery of a dominant-negative short isoform and gain-of-function neuronal effects revealed post-translational and morphogenic layers of SVCT2 regulation.","evidence":"FRET interaction of SVCT2sh with SVCT2wt plus uptake assays; lentiviral SVCT2-EYFP overexpression with MAP2/filopodia imaging and ERK phosphorylation in N2a cells","pmids":["24947427","26646539"],"confidence":"Medium","gaps":["Physiological abundance and regulation of the short isoform unknown","Whether ERK activation is direct or downstream of ascorbate cofactor functions unresolved"]},{"year":2015,"claim":"Identification of miRNA repression (miR-141/miR-200a, later miR-125a-5p) added post-transcriptional control to SVCT2 regulation in differentiation and injury.","evidence":"3'-UTR luciferase reporters, miRNA mimics/inhibitors, and functional differentiation/uptake readouts in BMSCs and cortical neurons","pmids":["25617715","27085842"],"confidence":"Medium","gaps":["In vivo contribution of these miRNAs to SVCT2 levels not established","Combinatorial miRNA regulation not modeled"]},{"year":2018,"claim":"Resolving two distinct ascorbate-driven trafficking routes explained how surface SVCT2 abundance is dynamically tuned by substrate availability.","evidence":"RUSH synchronized ER-to-PM trafficking, dominant-negative dynamin II/AP180/Rab11, brefeldin A/tunicamycin, and surface biotinylation/uptake assays","pmids":["29545069"],"confidence":"High","gaps":["Signal transducing extracellular ascorbate to trafficking machinery not identified","Cell-type generality of dual routes untested"]},{"year":2021,"claim":"Demonstration of p53/HDAC3 repression, ER localization, and vitamin C recycling-dependent neuronal effects integrated SVCT2 into epigenetic, organellar, and intercellular metabolic control.","evidence":"ChIP for p53/HDAC3 and histone acetylation with promoter mutagenesis; SVCT2 colocalization with ER markers; SVCT2 genetic models with GLUT1 inhibition in glia","pmids":["33580460","34573045"],"confidence":"Medium","gaps":["Functional role of ER-localized SVCT2 not defined","Direct downstream ascorbate-dependent enzymes in branching not pinpointed"]},{"year":2021,"claim":"Proposal of SVCT2 as a receptor-like transporter activating JAK2/STAT2 introduced a putative signaling function beyond transport.","evidence":"Co-immunoprecipitation of SVCT2–JAK2 and phosphorylation assays with mutant constructs","pmids":["33484802"],"confidence":"Low","gaps":["Single Co-IP/phosphorylation study not independently replicated","Whether signaling is separable from transport activity unestablished","Physiological relevance in vivo untested"]},{"year":2023,"claim":"Identification of urate as a second SVCT2 substrate competitively inhibited by ascorbate broadened the transporter's physiological substrate scope.","evidence":"SVCT2-expressing mammalian cell urate uptake assays with ascorbate inhibition kinetics, confirmed in mouse Svct2","pmids":["37390985"],"confidence":"Medium","gaps":["In vivo contribution to urate handling not established","Stoichiometry and physiological flux of urate transport unquantified"]},{"year":2023,"claim":"Defining NF-κB-dependent bidirectional regulation of SVCT2 in melanoma and lens epithelium tied transporter levels to oxidative-stress outcomes including ferroptosis and apoptosis.","evidence":"Blue-light and UVB models with NF-κB/ROS inhibitors, siRNA knockdown, and ascorbate uptake/ferroptosis-apoptosis markers","pmids":["37276798","37246402"],"confidence":"Medium","gaps":["Context determining whether NF-κB induces vs represses SVCT2 unresolved","Direct NF-κB binding to SVCT2 promoter not demonstrated in these studies"]},{"year":2025,"claim":"Discovery of the ERα–XIAP axis controlling SVCT2 protein stability and microglial gain-of-function neuroprotection extended SVCT2 regulation to ubiquitin-mediated turnover and disease-modifying roles.","evidence":"Co-IP, XIAP/ERα siRNA, ubiquitination and proteasome-rescue assays; microglial-targeted SVCT2 overexpression in 5xFAD mice with plaque/synaptic/behavioral readouts","pmids":["40731045","40907096"],"confidence":"Medium","gaps":["XIAP ubiquitination sites on SVCT2 not mapped","Mechanism by which microglial SVCT2 reprograms phenotype incompletely defined"]},{"year":null,"claim":"The transporter responsible for basolateral ascorbate efflux and the structural basis of SVCT2 substrate selection between ascorbate and urate remain unidentified.","evidence":"","pmids":[],"confidence":"Medium","gaps":["SLC23A2 does not mediate ascorbate efflux and the efflux carrier is unknown [#23]","No atomic structure to explain dual ascorbate/urate transport","Signaling vs transport functions not mechanistically separated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,8,15,34]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[0,34]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,13,28,30]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[28,30]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[28]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,8,34]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[14,36]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[17,18,31]}],"complexes":[],"partners":["JAK2","ESR1","XIAP","SLC23A2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UGH3","full_name":"Solute carrier family 23 member 2","aliases":["Na(+)/L-ascorbic acid transporter 2","Nucleobase transporter-like 1 protein","Sodium-dependent vitamin C transporter 2","hSVCT2","Yolk sac permease-like molecule 2"],"length_aa":650,"mass_kda":70.3,"function":"Sodium/ascorbate cotransporter (PubMed:10471399, PubMed:10556521). Mediates electrogenic uptake of vitamin C, with a stoichiometry of 2 Na(+) for each ascorbate (PubMed:10471399)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q9UGH3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC23A2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000089057","cell_line_id":"CID001377","localizations":[{"compartment":"membrane","grade":3},{"compartment":"vesicles","grade":3}],"interactors":[{"gene":"GLCCI1","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/target/CID001377","total_profiled":1310},"omim":[{"mim_id":"603791","title":"SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 2; SLC23A2","url":"https://www.omim.org/entry/603791"},{"mim_id":"240400","title":"HYPOASCORBEMIA","url":"https://www.omim.org/entry/240400"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Vesicles","reliability":"Uncertain"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"adrenal gland","ntpm":96.5},{"tissue":"retina","ntpm":99.4}],"url":"https://www.proteinatlas.org/search/SLC23A2"},"hgnc":{"alias_symbol":["SVCT2","KIAA0238","YSPL2"],"prev_symbol":["SLC23A1"]},"alphafold":{"accession":"Q9UGH3","domains":[{"cath_id":"-","chopping":"98-184_212-570","consensus_level":"medium","plddt":89.7762,"start":98,"end":570}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UGH3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UGH3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UGH3-F1-predicted_aligned_error_v6.png","plddt_mean":77.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC23A2","jax_strain_url":"https://www.jax.org/strain/search?query=SLC23A2"},"sequence":{"accession":"Q9UGH3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UGH3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UGH3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UGH3"}},"corpus_meta":[{"pmid":"19162177","id":"PMC_19162177","title":"Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2.","date":"2009","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19162177","citation_count":457,"is_preprint":false},{"pmid":"17541511","id":"PMC_17541511","title":"SVCT1 and SVCT2: key proteins for vitamin C uptake.","date":"2007","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/17541511","citation_count":284,"is_preprint":false},{"pmid":"10471399","id":"PMC_10471399","title":"Human placental sodium-dependent vitamin C transporter (SVCT2): molecular cloning and transport function.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10471399","citation_count":139,"is_preprint":false},{"pmid":"29872720","id":"PMC_29872720","title":"Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2.","date":"2018","source":"NPJ precision oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29872720","citation_count":108,"is_preprint":false},{"pmid":"15625716","id":"PMC_15625716","title":"Sodium vitamin C cotransporter SVCT2 is expressed in hypothalamic glial cells.","date":"2005","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/15625716","citation_count":90,"is_preprint":false},{"pmid":"15993839","id":"PMC_15993839","title":"Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15993839","citation_count":84,"is_preprint":false},{"pmid":"20541602","id":"PMC_20541602","title":"Low vitamin C and increased oxidative stress and cell death in mice that lack the sodium-dependent vitamin C transporter SVCT2.","date":"2010","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20541602","citation_count":77,"is_preprint":false},{"pmid":"25110615","id":"PMC_25110615","title":"Vitamin C Transporters, Recycling and the Bystander Effect in the Nervous System: SVCT2 versus Gluts.","date":"2014","source":"Journal of stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25110615","citation_count":73,"is_preprint":false},{"pmid":"23228664","id":"PMC_23228664","title":"Ascorbic acid enhances the expression of type 1 and type 4 collagen and SVCT2 in cultured human skin fibroblasts.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23228664","citation_count":69,"is_preprint":false},{"pmid":"17291984","id":"PMC_17291984","title":"Translational control of the ascorbic acid transporter SVCT2 in human platelets.","date":"2006","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17291984","citation_count":69,"is_preprint":false},{"pmid":"22665050","id":"PMC_22665050","title":"SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22665050","citation_count":68,"is_preprint":false},{"pmid":"12897061","id":"PMC_12897061","title":"Impaired adrenal catecholamine system function in mice with deficiency of the ascorbic acid transporter (SVCT2).","date":"2003","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12897061","citation_count":63,"is_preprint":false},{"pmid":"12887688","id":"PMC_12887688","title":"Effect of middle cerebral artery occlusion on mRNA expression for the sodium-coupled vitamin C transporter SVCT2 in rat brain.","date":"2003","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12887688","citation_count":58,"is_preprint":false},{"pmid":"16357110","id":"PMC_16357110","title":"Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery.","date":"2005","source":"American journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/16357110","citation_count":57,"is_preprint":false},{"pmid":"11446766","id":"PMC_11446766","title":"Vitamin C transport in human lens epithelial cells: evidence for the presence of SVCT2.","date":"2001","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/11446766","citation_count":53,"is_preprint":false},{"pmid":"19054284","id":"PMC_19054284","title":"The Na+-dependent L-ascorbic acid transporter SVCT2 expressed in brainstem cells, neurons, and neuroblastoma cells is inhibited by flavonoids.","date":"2008","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19054284","citation_count":51,"is_preprint":false},{"pmid":"20122894","id":"PMC_20122894","title":"Ascorbic acid depletion enhances expression of the sodium-dependent vitamin C transporters, SVCT1 and SVCT2, and uptake of ascorbic acid in livers of SMP30/GNL knockout mice.","date":"2010","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/20122894","citation_count":50,"is_preprint":false},{"pmid":"30054560","id":"PMC_30054560","title":"Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30054560","citation_count":50,"is_preprint":false},{"pmid":"15316768","id":"PMC_15316768","title":"Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2.","date":"2004","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15316768","citation_count":48,"is_preprint":false},{"pmid":"17643393","id":"PMC_17643393","title":"Redox regulation of vitamin C transporter SVCT2 in C2C12 myotubes.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17643393","citation_count":47,"is_preprint":false},{"pmid":"19346260","id":"PMC_19346260","title":"Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer.","date":"2009","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/19346260","citation_count":46,"is_preprint":false},{"pmid":"22001929","id":"PMC_22001929","title":"Differential regulation of the ascorbic acid transporter SVCT2 during development and in response to ascorbic acid depletion.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22001929","citation_count":46,"is_preprint":false},{"pmid":"22171153","id":"PMC_22171153","title":"Association between a SLC23A2 gene variation, plasma vitamin C levels, and risk of glaucoma in a Mediterranean population.","date":"2011","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/22171153","citation_count":45,"is_preprint":false},{"pmid":"19232538","id":"PMC_19232538","title":"Macrophage differentiation increases expression of the ascorbate transporter (SVCT2).","date":"2009","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19232538","citation_count":44,"is_preprint":false},{"pmid":"24739976","id":"PMC_24739976","title":"Orally administrated ascorbic acid suppresses neuronal damage and modifies expression of SVCT2 and GLUT1 in the brain of diabetic rats with cerebral ischemia-reperfusion.","date":"2014","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/24739976","citation_count":42,"is_preprint":false},{"pmid":"19672970","id":"PMC_19672970","title":"Sodium-dependent vitamin C transporter 2 (SVCT2) is necessary for the uptake of L-ascorbic acid into Schwann cells.","date":"2010","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/19672970","citation_count":41,"is_preprint":false},{"pmid":"23737080","id":"PMC_23737080","title":"Vitamin C transporter gene (SLC23A1 and SLC23A2) polymorphisms, plasma vitamin C levels, and gastric cancer risk in the EPIC cohort.","date":"2013","source":"Genes & nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/23737080","citation_count":40,"is_preprint":false},{"pmid":"10841345","id":"PMC_10841345","title":"The vitamin C transporter SVCT2 is expressed by astrocytes in culture but not in situ.","date":"2000","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/10841345","citation_count":40,"is_preprint":false},{"pmid":"11036152","id":"PMC_11036152","title":"Sodium-ascorbate cotransport controls intracellular ascorbate concentration in primary astrocyte cultures expressing the SVCT2 transporter.","date":"2000","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11036152","citation_count":39,"is_preprint":false},{"pmid":"23089627","id":"PMC_23089627","title":"Sodium-dependent vitamin C transporter SVCT2: expression and function in bone marrow stromal cells and in osteogenesis.","date":"2012","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/23089627","citation_count":36,"is_preprint":false},{"pmid":"25617715","id":"PMC_25617715","title":"MicroRNAs-141 and 200a regulate the SVCT2 transporter in bone marrow stromal cells.","date":"2015","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25617715","citation_count":34,"is_preprint":false},{"pmid":"27085842","id":"PMC_27085842","title":"SVCT2, a potential therapeutic target, protects against oxidative stress during ethanol-induced neurotoxicity via JNK/p38 MAPKs, NF-κB and miRNA125a-5p.","date":"2016","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27085842","citation_count":34,"is_preprint":false},{"pmid":"28385602","id":"PMC_28385602","title":"SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts.","date":"2017","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/28385602","citation_count":34,"is_preprint":false},{"pmid":"21347255","id":"PMC_21347255","title":"Sodium-dependent vitamin C transporter 2 (SVCT2) expression and activity in brain capillary endothelial cells after transient ischemia in mice.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21347255","citation_count":29,"is_preprint":false},{"pmid":"23964197","id":"PMC_23964197","title":"SVCT2 vitamin C transporter expression in progenitor cells of the postnatal neurogenic niche.","date":"2013","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23964197","citation_count":28,"is_preprint":false},{"pmid":"27382510","id":"PMC_27382510","title":"Vitamin C is taken up by human T cells via sodium-dependent vitamin C transporter 2 (SVCT2) and exerts inhibitory effects on the activation of these cells in vitro.","date":"2016","source":"Anatomy & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27382510","citation_count":28,"is_preprint":false},{"pmid":"19216494","id":"PMC_19216494","title":"Hierarchal contribution of N- and C-terminal sequences to the differential localization of homologous sodium-dependent vitamin C transporters, SVCT1 and SVCT2, in epithelial cells.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19216494","citation_count":27,"is_preprint":false},{"pmid":"31607868","id":"PMC_31607868","title":"SVCT2 Promotes Neural Stem/Progenitor Cells Migration Through Activating CDC42 After Ischemic Stroke.","date":"2019","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31607868","citation_count":26,"is_preprint":false},{"pmid":"24365600","id":"PMC_24365600","title":"Knockdown of SVCT2 impairs in-vitro cell attachment, migration and wound healing in bone marrow stromal cells.","date":"2013","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/24365600","citation_count":25,"is_preprint":false},{"pmid":"24947427","id":"PMC_24947427","title":"SVCT2 transporter expression is post-natally induced in cortical neurons and its function is regulated by its short isoform.","date":"2014","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24947427","citation_count":22,"is_preprint":false},{"pmid":"15921655","id":"PMC_15921655","title":"Chondrocyte transport and concentration of ascorbic acid is mediated by SVCT2.","date":"2005","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15921655","citation_count":22,"is_preprint":false},{"pmid":"22763122","id":"PMC_22763122","title":"Downregulation of vitamin C transporter SVCT-2 in doxorubicin-induced cardiomyocyte injury.","date":"2012","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22763122","citation_count":22,"is_preprint":false},{"pmid":"34573045","id":"PMC_34573045","title":"SVCT2 Overexpression and Ascorbic Acid Uptake Increase Cortical Neuron Differentiation, Which Is Dependent on Vitamin C Recycling between Neurons and Astrocytes.","date":"2021","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34573045","citation_count":21,"is_preprint":false},{"pmid":"26210298","id":"PMC_26210298","title":"The crucial role of vitamin C and its transporter (SVCT2) in bone marrow stromal cell autophagy and apoptosis.","date":"2015","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/26210298","citation_count":21,"is_preprint":false},{"pmid":"22558179","id":"PMC_22558179","title":"Increased expression of SVCT2 in a new mouse model raises ascorbic acid in tissues and protects against paraquat-induced oxidative damage in lung.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22558179","citation_count":19,"is_preprint":false},{"pmid":"25242204","id":"PMC_25242204","title":"High-dose vitamin C supplementation increases skeletal muscle vitamin C concentration and SVCT2 transporter expression but does not alter redox status in healthy males.","date":"2014","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25242204","citation_count":19,"is_preprint":false},{"pmid":"31901552","id":"PMC_31901552","title":"Enhanced Anticancer Effect of Adding Magnesium to Vitamin C Therapy: Inhibition of Hormetic Response by SVCT-2 Activation.","date":"2019","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31901552","citation_count":19,"is_preprint":false},{"pmid":"37424994","id":"PMC_37424994","title":"Role of vitamin C and SVCT2 in neurogenesis.","date":"2023","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37424994","citation_count":18,"is_preprint":false},{"pmid":"24400138","id":"PMC_24400138","title":"The human sodium-dependent ascorbic acid transporters SLC23A1 and SLC23A2 do not mediate ascorbic acid release in the proximal renal epithelial cell.","date":"2013","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/24400138","citation_count":18,"is_preprint":false},{"pmid":"23916956","id":"PMC_23916956","title":"Expression and/or activity of the SVCT2 ascorbate transporter may be decreased in many aggressive cancers, suggesting potential utility for sodium bicarbonate and dehydroascorbic acid in cancer therapy.","date":"2013","source":"Medical hypotheses","url":"https://pubmed.ncbi.nlm.nih.gov/23916956","citation_count":18,"is_preprint":false},{"pmid":"11584081","id":"PMC_11584081","title":"Characterization of the genomic structure of the human vitamin C transporter SVCT1 (SLC23A2).","date":"2001","source":"The Journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/11584081","citation_count":18,"is_preprint":false},{"pmid":"19125272","id":"PMC_19125272","title":"The ascorbic acid transporter SVCT2 is expressed in slow-twitch skeletal muscle fibres.","date":"2009","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19125272","citation_count":18,"is_preprint":false},{"pmid":"28942474","id":"PMC_28942474","title":"SVCT2 Expression and Function in Reactive Astrocytes Is a Common Event in Different Brain Pathologies.","date":"2017","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/28942474","citation_count":17,"is_preprint":false},{"pmid":"22990596","id":"PMC_22990596","title":"Dynamic expression of the sodium-vitamin C co-transporters, SVCT1 and SVCT2, during perinatal kidney development.","date":"2012","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22990596","citation_count":17,"is_preprint":false},{"pmid":"37276798","id":"PMC_37276798","title":"Blue light promotes vitamin C-mediated ferroptosis of melanoma through specifically upregulating transporter SVCT2 and generating Fe2.","date":"2023","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/37276798","citation_count":17,"is_preprint":false},{"pmid":"26646539","id":"PMC_26646539","title":"SVCT2 Overexpression in Neuroblastoma Cells Induces Cellular Branching that is Associated with ERK Signaling.","date":"2015","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/26646539","citation_count":16,"is_preprint":false},{"pmid":"36436457","id":"PMC_36436457","title":"SVCT2-mediated ascorbic acid uptake buffers stress responses via DNA hydroxymethylation reprogramming of S100 calcium-binding protein A4 gene.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/36436457","citation_count":16,"is_preprint":false},{"pmid":"28097475","id":"PMC_28097475","title":"SVCT2 Is Expressed by Cerebellar Precursor Cells, Which Differentiate into Neurons in Response to Ascorbic Acid.","date":"2017","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/28097475","citation_count":16,"is_preprint":false},{"pmid":"27957816","id":"PMC_27957816","title":"Ascorbic acid drives the differentiation of mesoderm-derived embryonic stem cells. Involvement of p38 MAPK/CREB and SVCT2 transporter.","date":"2017","source":"Molecular nutrition & food research","url":"https://pubmed.ncbi.nlm.nih.gov/27957816","citation_count":16,"is_preprint":false},{"pmid":"23415019","id":"PMC_23415019","title":"Sodium-coupled vitamin C transporter (SVCT2): expression, function, and regulation in intervertebral disc cells.","date":"2013","source":"The spine journal : official journal of the North American Spine Society","url":"https://pubmed.ncbi.nlm.nih.gov/23415019","citation_count":15,"is_preprint":false},{"pmid":"37246402","id":"PMC_37246402","title":"Ultraviolet B radiation induces oxidative stress and apoptosis in human lens epithelium cells by activating NF-κB signaling to down-regulate sodium vitamin C transporter 2 (SVCT2) expression.","date":"2023","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/37246402","citation_count":14,"is_preprint":false},{"pmid":"27596508","id":"PMC_27596508","title":"Apical Polarization of SVCT2 in Apical Radial Glial Cells and Progenitors During Brain Development.","date":"2016","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/27596508","citation_count":14,"is_preprint":false},{"pmid":"16380174","id":"PMC_16380174","title":"Functional analysis of two regulatory regions of the human Na+ -dependent vitamin C transporter 2, SLC23A2, in human vascular smooth muscle cells.","date":"2005","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/16380174","citation_count":14,"is_preprint":false},{"pmid":"31249848","id":"PMC_31249848","title":"Data on SVCT2 transporter expression and localization in cancer cell lines and tissues.","date":"2019","source":"Data in brief","url":"https://pubmed.ncbi.nlm.nih.gov/31249848","citation_count":13,"is_preprint":false},{"pmid":"25102111","id":"PMC_25102111","title":"Molecular expression and functional activity of vitamin C specific transport system (SVCT2) in human breast cancer cells.","date":"2014","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/25102111","citation_count":13,"is_preprint":false},{"pmid":"25014399","id":"PMC_25014399","title":"Functional characterization and molecular identification of vitamin C transporter (SVCT2) in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells.","date":"2014","source":"Current eye research","url":"https://pubmed.ncbi.nlm.nih.gov/25014399","citation_count":13,"is_preprint":false},{"pmid":"21335086","id":"PMC_21335086","title":"Regulation of the human ascorbate transporter SVCT2 exon 1b gene by zinc-finger transcription factors.","date":"2011","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21335086","citation_count":13,"is_preprint":false},{"pmid":"21770893","id":"PMC_21770893","title":"CpG methylation at the USF-binding site mediates cell-specific transcription of human ascorbate transporter SVCT2 exon 1a.","date":"2011","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/21770893","citation_count":13,"is_preprint":false},{"pmid":"19254685","id":"PMC_19254685","title":"Oxidized lipoprotein induces the macrophage ascorbate transporter (SVCT2): protection by intracellular ascorbate against oxidant stress and apoptosis.","date":"2009","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/19254685","citation_count":13,"is_preprint":false},{"pmid":"23708151","id":"PMC_23708151","title":"Liver metabolic/oxidative stress induces hepatic and extrahepatic changes in the expression of the vitamin C transporters SVCT1 and SVCT2.","date":"2013","source":"European journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/23708151","citation_count":12,"is_preprint":false},{"pmid":"29545069","id":"PMC_29545069","title":"Ascorbic acid increases SVCT2 localization at the plasma membrane by accelerating its trafficking from early secretory compartments and through the endocytic-recycling pathway.","date":"2018","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29545069","citation_count":12,"is_preprint":false},{"pmid":"33484802","id":"PMC_33484802","title":"New insights into Vitamin C function: Vitamin C induces JAK2 activation through its receptor-like transporter SVCT2.","date":"2021","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33484802","citation_count":12,"is_preprint":false},{"pmid":"26838684","id":"PMC_26838684","title":"Fruit and vegetable intake and vitamin C transporter gene (SLC23A2) polymorphisms in chronic lymphocytic leukaemia.","date":"2016","source":"European journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/26838684","citation_count":11,"is_preprint":false},{"pmid":"23321552","id":"PMC_23321552","title":"Combined vitamin C and E deficiency induces motor defects in gulo(-/-)/SVCT2(+/-) mice.","date":"2012","source":"Nutritional neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23321552","citation_count":11,"is_preprint":false},{"pmid":"21176777","id":"PMC_21176777","title":"Up-regulation of the vitamin C transporter SVCT2 upon differentiation and depolarization of myotubes.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/21176777","citation_count":11,"is_preprint":false},{"pmid":"20549544","id":"PMC_20549544","title":"Oxidized LDL up-regulates the ascorbic acid transporter SVCT2 in endothelial cells.","date":"2010","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20549544","citation_count":11,"is_preprint":false},{"pmid":"33677235","id":"PMC_33677235","title":"Ascorbic acid analogue 6-Deoxy-6-[18F] fluoro-L-ascorbic acid as a tracer for identifying human colorectal cancer with SVCT2 overexpression.","date":"2021","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33677235","citation_count":10,"is_preprint":false},{"pmid":"36690706","id":"PMC_36690706","title":"SVCT2-GLUT1-mediated ascorbic acid transport pathway in rat dental pulp and its effects during wound healing.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/36690706","citation_count":9,"is_preprint":false},{"pmid":"24578608","id":"PMC_24578608","title":"Genetic polymorphisms in SLC23A2 as predictive biomarkers of severe acute toxicities after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.","date":"2014","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24578608","citation_count":9,"is_preprint":false},{"pmid":"22532872","id":"PMC_22532872","title":"Interaction of the transcription start site core region and transcription factor YY1 determine ascorbate transporter SVCT2 exon 1a promoter activity.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22532872","citation_count":9,"is_preprint":false},{"pmid":"37322603","id":"PMC_37322603","title":"Curcumin inhibits human cancer cell growth and migration through downregulation of SVCT2.","date":"2023","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/37322603","citation_count":8,"is_preprint":false},{"pmid":"24932237","id":"PMC_24932237","title":"SLC23A2-05 (rs4987219) and KRAS-LCS6 (rs61764370) polymorphisms in patients with squamous cell carcinoma of the head and neck.","date":"2014","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/24932237","citation_count":8,"is_preprint":false},{"pmid":"37390985","id":"PMC_37390985","title":"SVCT2/SLC23A2 is a sodium-dependent urate transporter: functional properties and practical application.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37390985","citation_count":7,"is_preprint":false},{"pmid":"37330196","id":"PMC_37330196","title":"Construction of a Brain-specific SLC23A2 Gene Knockout Mice Model.","date":"2023","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37330196","citation_count":6,"is_preprint":false},{"pmid":"32580031","id":"PMC_32580031","title":"SVCT2-Dependent plasma and mitochondrial membrane transport of ascorbic acid in differentiating myoblasts.","date":"2020","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/32580031","citation_count":6,"is_preprint":false},{"pmid":"31467227","id":"PMC_31467227","title":"Association of Leukemia Target Genes Tet2, Bcl2, and Slc23a2 in Vitamin C Pathways.","date":"2019","source":"Cancer genomics & proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/31467227","citation_count":5,"is_preprint":false},{"pmid":"33580460","id":"PMC_33580460","title":"Role of p53 in transcriptional repression of SVCT2.","date":"2021","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/33580460","citation_count":5,"is_preprint":false},{"pmid":"38180226","id":"PMC_38180226","title":"Ascorbic acid and its transporter SVCT2, affect radial glia cells differentiation in postnatal stages.","date":"2024","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/38180226","citation_count":4,"is_preprint":false},{"pmid":"23329419","id":"PMC_23329419","title":"The vitamin C transporter SVCT2 is down-regulated during postnatal development of slow skeletal muscles.","date":"2013","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23329419","citation_count":4,"is_preprint":false},{"pmid":"34405001","id":"PMC_34405001","title":"Mutation SVCT2 promotes cell proliferation, invasion and migration in colorectal cancer.","date":"2021","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34405001","citation_count":3,"is_preprint":false},{"pmid":"35417255","id":"PMC_35417255","title":"ATRX-dependent SVCT2 mediates macrophage infiltration in the glioblastoma xenograft model.","date":"2022","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/35417255","citation_count":3,"is_preprint":false},{"pmid":"22142801","id":"PMC_22142801","title":"Molecular characterization and transcriptional regulation of the sodium-dependent vitamin C transporter genes (slc23a1 and slc23a2) in a teleost fish, the Senegalese sole (Solea senegalensis).","date":"2011","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22142801","citation_count":3,"is_preprint":false},{"pmid":"28177761","id":"PMC_28177761","title":"Temporo-spacial microanatomical distribution of the murine sodium-dependent ascorbic acid transporters Slc23a1 and Slc23a2 in the kidney throughout development.","date":"2016","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/28177761","citation_count":3,"is_preprint":false},{"pmid":"39855109","id":"PMC_39855109","title":"SVCT2-targeted PET imaging agent for the evaluation of LN metastasis of thyroid cancer.","date":"2025","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39855109","citation_count":3,"is_preprint":false},{"pmid":"38972487","id":"PMC_38972487","title":"Modulation of microglia activation by the ascorbic acid transporter SVCT2.","date":"2024","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/38972487","citation_count":1,"is_preprint":false},{"pmid":"41113559","id":"PMC_41113559","title":"Oxidative stress-mediated apoptosis via the SLC23A2-ascorbic acid interaction contributes to cleft lip development.","date":"2025","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/41113559","citation_count":1,"is_preprint":false},{"pmid":"40456835","id":"PMC_40456835","title":"Novel susceptibility gene SLC23A2 functions via PI3K-AKT-mTOR pathway in etiology of non-syndromic cleft palate.","date":"2025","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40456835","citation_count":0,"is_preprint":false},{"pmid":"40731045","id":"PMC_40731045","title":"Estrogen receptor α regulates SVCT2 protein level in human breast cancer cells.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40731045","citation_count":0,"is_preprint":false},{"pmid":"36310070","id":"PMC_36310070","title":"Impact of SLC23A1 and SLC23A2 Polymorphisms on the Risk for Preeclampsia in a Chinese Han Population.","date":"2022","source":"Journal of nutritional science and vitaminology","url":"https://pubmed.ncbi.nlm.nih.gov/36310070","citation_count":0,"is_preprint":false},{"pmid":"40907096","id":"PMC_40907096","title":"Enhancing microglial antioxidant capacity via the ascorbate transporter SVCT2 delays onset and modifies disease progression in mouse models of Alzheimer's disease.","date":"2025","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/40907096","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51424,"output_tokens":10494,"usd":0.155841,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":21259,"output_tokens":5128,"usd":0.117248,"stage2_stop_reason":"end_turn"},"total_usd":0.273089,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Human SVCT2 (hSVCT2) encodes a 650 amino acid, ~70 kDa protein that mediates sodium-dependent, saturable transport of ascorbic acid with a Km of 69 µM and a Na⁺:ascorbate stoichiometry of 2:1, establishing it as a secondary active transporter.\",\n      \"method\": \"Functional expression of hSVCT2 cDNA in mammalian cells; radiolabeled ascorbate uptake assays; Na⁺ activation kinetics\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct reconstitution via cDNA expression, saturation kinetics, and Na⁺ stoichiometry established in a dedicated cloning/characterization paper\",\n      \"pmids\": [\"10471399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In polarized epithelial cells (Caco-2 and MDCK), SVCT2-EGFP localizes predominantly to the basolateral membrane, whereas SVCT1 localizes apically; basolateral SVCT2 function was confirmed by ascorbate uptake assays with basolateral membrane exposure. An N-terminal basolateral targeting sequence (BTS) conserved among mammalian SVCT2 forms is responsible for this sorting.\",\n      \"method\": \"EGFP-tagged SVCT constructs expressed in MDCK and Caco-2 cells; confocal microscopy; Transwell ascorbate transport assays; domain-swap and point-mutation analysis\",\n      \"journal\": \"Biochemical and biophysical research communications / Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — replicated across two papers with confocal imaging, functional transport assays, and mutagenesis identifying the targeting sequence\",\n      \"pmids\": [\"15993839\", \"19216494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"SVCT2 is expressed in cultured astrocytes (Northern blot) but in situ hybridization detects SVCT2 mRNA only in neurons and not in normal astrocytes in vivo, indicating that astrocyte SVCT2 expression is an artifact of culture conditions and that in the intact brain SVCT2 is neuron-specific.\",\n      \"method\": \"Northern blot analysis of cultured astrocytes; in situ hybridization on brain sections; quinolinic acid neurotoxin challenge model\",\n      \"journal\": \"Neuroreport\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal methods (Northern + ISH) in one study; however later work showed ischemia-induced astrocyte SVCT2 expression, qualifying the neuron-specificity claim to baseline conditions\",\n      \"pmids\": [\"10841345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"SVCT2-mediated Na⁺-ascorbate cotransport across the plasma membrane is the primary determinant of steady-state intracellular ascorbic acid concentration in primary astrocyte cultures; transport activity and intracellular ascorbate are modulated by cAMP, hyposmotic swelling, and extracellular Na⁺ and K⁺ levels.\",\n      \"method\": \"SVCT2 expression detected by Northern blot in rat brain and cultured astrocytes; mathematical modeling validated against experimental ascorbate uptake measurements under varying ionic and osmotic conditions\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Northern blot combined with functional transport assays and validated mathematical model; single lab\",\n      \"pmids\": [\"11036152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SVCT2 (but not SVCT1) mediates Na⁺-dependent, saturable ascorbic acid uptake in human lens epithelial cells (HLE-B3); SVCT2 gene expression is upregulated by oxidant stress (tert-butylhydroperoxide), and uptake is partially modulated by cAMP, cytochalasin B, and phorbol ester signaling.\",\n      \"method\": \"RT-PCR for SVCT isoform identification; radiolabeled (¹⁴C) ascorbate uptake assays; inhibitor studies; gene expression analysis\",\n      \"journal\": \"Experimental eye research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RT-PCR plus functional uptake assays with pharmacological dissection; single lab\",\n      \"pmids\": [\"11446766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SVCT2 null mice show severely reduced ascorbic acid in fetal cortex, placenta, and lung (but not liver, the site of synthesis); adrenal medullary catecholamine synthesis is impaired—norepinephrine decreased 50%, epinephrine 81%—with depletion of chromaffin cell secretory vesicles and increased apoptosis, establishing SVCT2 as essential for ascorbate-dependent dopamine β-hydroxylase activity in the adrenal medulla.\",\n      \"method\": \"SVCT2 knockout mouse model; HPLC catecholamine measurements; electron microscopy of chromaffin cells; plasma corticosterone assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with multiple orthogonal readouts (biochemical, ultrastructural, endocrine), replicated across tissues\",\n      \"pmids\": [\"12897061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Focal cerebral ischemia (middle cerebral artery occlusion) upregulates SVCT2 mRNA in both neurons and astrocytes in the peri-infarct zone, providing in situ evidence for SVCT2 expression in reactive astrocytes—the first demonstration of astrocytic SVCT2 in situ.\",\n      \"method\": \"In situ hybridization on rat brain sections 2 h and 22 h after MCAO\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ISH with temporal controls in a defined injury model; single lab, single method\",\n      \"pmids\": [\"12887688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"SVCT2 is highly expressed in the apical membranes of hypothalamic tanycytes (specialized ependymal/glial cells) and mediates high-affinity ascorbic acid uptake in these cells, providing the mechanism by which ascorbate is concentrated in the hypothalamic region.\",\n      \"method\": \"In situ hybridization; ultrastructural immunocytochemistry; primary tanycyte cultures with functional ascorbate uptake assays\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (ISH, immunoEM, functional uptake in primary cultures) in a single study\",\n      \"pmids\": [\"15625716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"SVCT2 is the sole active transporter for ascorbic acid in primary human chondrocytes; siRNA knockdown of SVCT2 abolishes the active (Na⁺-dependent, saturable, concentrative) component of ascorbate transport, and these cells can concentrate ascorbate ~960-fold over extracellular levels.\",\n      \"method\": \"Radiolabeled ascorbate uptake assays; RT-PCR isoform identification; siRNA knockdown of SVCT2\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — siRNA knockdown with functional rescue readout combined with kinetic characterization; clean loss-of-function with specific phenotype\",\n      \"pmids\": [\"15921655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SVCT2 expression in anucleated human platelets is regulated at the translational level; platelets compensate for fluctuations in ascorbate levels by modulating SVCT2 protein expression post-transcriptionally, and SVCT2 upregulation occurs during platelet activation accompanied by vitamin C depletion.\",\n      \"method\": \"Western blot and functional ascorbate uptake in isolated anucleated platelets; platelet activation assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — use of anucleated cells provides direct evidence for translational control; single lab with two orthogonal approaches (protein expression + functional transport)\",\n      \"pmids\": [\"17291984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SVCT2 transcription in C2C12 myotubes is redox-regulated: H₂O₂ upregulates SVCT2 gene expression and lipoate (antioxidant) downregulates it, with the effect mediated through AP-1 and NF-κB signaling pathways.\",\n      \"method\": \"SVCT2 mRNA quantification in C2C12 myotubes treated with H₂O₂ or lipoate; pharmacological inhibition of AP-1/NF-κB\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — mRNA-level readouts with pathway inhibitors; single lab, multiple consistent treatments\",\n      \"pmids\": [\"17643393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SVCT2 is expressed and functional in rat brainstem cells, cortical neurons, cerebellar neurons, and neuroblastoma cells; the transporter displays two kinetically distinct affinity components for ascorbate, and flavonoids (notably quercetin) dose-dependently inhibit SVCT2-mediated ascorbate transport.\",\n      \"method\": \"RT-PCR; immunohistochemistry/ISH in fetal and adult rat brain; radiolabeled ascorbate uptake kinetics; dose-response inhibition with flavonoids\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell types characterized with functional assays; single lab, orthogonal methods\",\n      \"pmids\": [\"19054284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PMA-induced monocyte-to-macrophage differentiation markedly increases SVCT2 mRNA, protein, and transport function through a pathway requiring sustained activation of PKCβI/II → MEK/ERK (MAP kinase), with additional contributions from NADPH oxidase, NF-κB, and both known SVCT2 promoters.\",\n      \"method\": \"THP-1 monocyte differentiation model; SVCT2 mRNA/protein quantification; pharmacological inhibition of PKC isoforms (isoform-selective inhibitors), MEK/ERK, NF-κB, NADPH oxidase; promoter reporter assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal inhibitor approaches defining a specific signaling cascade, combined with promoter analysis; single lab but rigorous multi-method design\",\n      \"pmids\": [\"19232538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SVCT2 in epithelial cells contains a hierarchically dominant N-terminal basolateral targeting sequence (BTS) and a C-terminal sequence required for plasma membrane incorporation and retention; deletion of the BTS redirects SVCT2 to the apical membrane, and C-terminal deletion results in intracellular accumulation regardless of the BTS.\",\n      \"method\": \"Domain-swap, deletion, insertion, and point-mutation of EGFP-tagged SVCT1/SVCT2 constructs stably expressed in MDCK cells; confocal microscopy; Transwell ascorbate transport assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structure-function mutagenesis with functional validation across multiple constructs; defines molecular determinants of polarized sorting\",\n      \"pmids\": [\"19216494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SVCT2 null mice exhibit reduced vitamin C levels in fetal placenta and cortex (but not liver), elevated oxidative stress markers (malondialdehyde, isoketals, F₂-isoprostanes, F₄-neuroprostanes), cortical and brainstem hemorrhage, increased apoptosis, and basement membrane disruption, establishing that SVCT2 is critical for maintaining fetal vitamin C levels and survival.\",\n      \"method\": \"SVCT2 knockout mouse model; HPLC ascorbate measurements; lipid peroxidation biomarkers; immunohistochemistry for apoptosis and basement membrane proteins\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — whole-animal KO with genotype-dependent ascorbate levels and multiple oxidative stress biomarkers across tissues\",\n      \"pmids\": [\"20541602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SVCT2 is the primary mediator of ascorbic acid uptake into Schwann cells; siRNA-mediated knockdown and phloretin inhibition significantly reduce ¹⁴C-ascorbate uptake, and SVCT2 is localized to uncompacted myelin compartments of Schwann cells, with transport activity dependent on extracellular Na⁺, Mg²⁺, and Ca²⁺.\",\n      \"method\": \"Immunohistochemistry, immunoblotting, RT-PCR in peripheral nerve and Schwann cell cultures; ¹⁴C-ascorbate uptake assays; siRNA knockdown; phloretin inhibition; ex vivo uptake in sciatic nerve\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA KD with functional readout plus pharmacological inhibition and ex vivo validation; multiple orthogonal methods\",\n      \"pmids\": [\"19672970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Ascorbic acid depletion in SMP30/GNL knockout mouse hepatocytes enhances SVCT2 (and SVCT1) mRNA expression and increases ascorbate uptake, demonstrating that intracellular ascorbic acid negatively regulates SVCT2 expression in the liver.\",\n      \"method\": \"SMP30/GNL KO mouse model (ascorbate synthesis-deficient); SVCT mRNA quantification in tissues; primary hepatocyte culture ascorbate uptake assays\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic model with functional uptake confirmation in primary cells; single lab\",\n      \"pmids\": [\"20122894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The SVCT2 exon 1b promoter (CpG-rich, ubiquitously expressed) is regulated by a functional initiator that binds YY1, which cooperates with upstream Sp1/Sp3 elements; YY1/Sp1 and YY1/Sp3 complexes synergistically activate the exon 1b promoter, and EGR-1, EGR-2, WT1, and MAZ differentially regulate activity through overlapping GC-box elements.\",\n      \"method\": \"Promoter deletion constructs; EMSA with YY1/Sp antibody supershifts; co-transfection reporter assays in multiple cell lines\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA and reporter assays; single lab but multiple constructs and transcription factors tested\",\n      \"pmids\": [\"21335086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Cell-specific transcription from the CpG-poor SVCT2 exon 1a promoter is controlled by cooperative binding of NF-Y and USF to Y-box and E-box elements; CpG methylation at the upstream USF-binding site impairs both USF binding and NF-Y/USF complex formation, silencing exon 1a transcription in a cell-type-specific manner.\",\n      \"method\": \"Promoter deletion/mutation constructs; EMSA with antibody supershifts; bisulfite methylation analysis; decitabine demethylation experiments; co-transfection reporter assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — mutagenesis, EMSA, methylation analysis, and pharmacological demethylation all converge on the same CpG-site mechanism\",\n      \"pmids\": [\"21770893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SVCT2 is expressed in bone marrow stromal cells (BMSCs) as the sole ascorbate transporter; SVCT2 expression is upregulated during osteogenic differentiation (maximal at earliest phase), and lentiviral shRNA knockdown of SVCT2 inhibits osteogenesis; redox status positively (oxidant Sin-1) or negatively (ascorbic acid) modulates SVCT2 expression in BMSCs.\",\n      \"method\": \"RT-PCR; ¹⁴C-ascorbate uptake assays (Na⁺-dependent, saturable); lentiviral shRNA KD of SVCT2; osteogenic differentiation assays; redox treatments\",\n      \"journal\": \"Stem cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function with defined osteogenic phenotype, kinetic transport characterization, and redox regulation; multiple methods\",\n      \"pmids\": [\"23089627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Doxorubicin reduces SVCT2 expression and localization at the sarcolemma of cardiomyocytes; vitamin C supplementation blunts this reduction, suggesting that SVCT2 downregulation contributes to doxorubicin-induced cardiotoxicity by impairing ascorbate uptake.\",\n      \"method\": \"Isolated rat cardiomyocytes; Western blot and immunofluorescence localization of SVCT2; oxidative stress and apoptosis markers\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — protein expression and localization data with pharmacological intervention; single lab, no genetic KD confirmation\",\n      \"pmids\": [\"22763122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SVCT2 transgenic mice (global SVCT2 overexpression) show increased SVCT2 mRNA and correspondingly increased ascorbic acid levels in all organs except liver; this elevated ascorbate protects against paraquat-induced oxidative stress in lung (reduced F₂-isoprostanes).\",\n      \"method\": \"SVCT2 transgenic mouse model; qRT-PCR; HPLC ascorbate measurements; F₂-isoprostane oxidative stress markers; paraquat oxidative challenge\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic gain-of-function model with biochemical readouts; single lab\",\n      \"pmids\": [\"22558179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SVCT2 knockdown in BMSCs decreases cell attachment, spreading, trans-well migration, and wound healing; supplementation with vitamin C rescues these defects in wild-type but not SVCT2-knockdown cells; SVCT2 KD and oxidative stress alter cytoskeletal (F-actin) dynamics and activate p38 MAPK phosphorylation, which is inhibited by vitamin C.\",\n      \"method\": \"Lentiviral shRNA SVCT2 knockdown in BMSCs; cell adhesion, trans-well migration, and scratch wound assays; F-actin staining; p38 MAPK phosphorylation Western blot\",\n      \"journal\": \"Stem cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with multiple functional phenotypic readouts and signaling pathway analysis; single lab\",\n      \"pmids\": [\"24365600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SLC23A2/SVCT2 does not mediate ascorbic acid efflux (release) in renal proximal tubular epithelial cells; SLC23A2 is not expressed in the human proximal tubule, and a Xenopus oocyte dual-transporter system confirmed that SLC23A1 also does not mediate basolateral ascorbate release, indicating the efflux mechanism remains unidentified.\",\n      \"method\": \"Xenopus laevis oocyte expression system (dual-transporter assay); mammalian cell overexpression; human tissue gene expression analysis\",\n      \"journal\": \"Physiological reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution in Xenopus oocytes is rigorous; finding is a defined NEGATIVE result for efflux function of SLC23A2\",\n      \"pmids\": [\"24400138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SVCT2 overexpression in N2a neuroblastoma cells induces increased MAP2+ neurites and filopodia formation; SVCT2 overexpression combined with ascorbate treatment promotes ERK1/2 phosphorylation, linking SVCT2-mediated ascorbate uptake to ERK signaling during neuronal branching.\",\n      \"method\": \"Lentiviral SVCT2-EYFP overexpression in N2a cells; immunofluorescence for MAP2 and filopodia; Western blot for ERK1/2 phosphorylation\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — gain-of-function with defined morphological and signaling readouts; single lab, two methods\",\n      \"pmids\": [\"26646539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A short isoform of SVCT2 (SVCT2sh) interacts physically with full-length SVCT2 (SVCT2wt), as shown by FRET, and co-expression of SVCT2sh inhibits ascorbate uptake by SVCT2wt in N2a cells, indicating that the short isoform acts as a dominant-negative regulator of transporter function.\",\n      \"method\": \"FRET analysis of co-expressed SVCT2wt and SVCT2sh in N2a cells; ¹⁴C-ascorbate uptake assays\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRET for protein-protein interaction and functional transport assay; single lab, two orthogonal methods\",\n      \"pmids\": [\"24947427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-141 and miR-200a directly repress SVCT2 expression by targeting the 3'-UTR of SVCT2 mRNA in BMSCs, reducing osteogenic differentiation; miRNA inhibitors restore SVCT2 expression and osteogenic gene expression.\",\n      \"method\": \"3'-UTR luciferase reporter assays; miRNA mimic and inhibitor transfections; SVCT2 protein quantification; osteogenic differentiation assays in mouse BMSCs\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — 3'-UTR reporter plus functional phenotype; single lab, two methods\",\n      \"pmids\": [\"25617715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SVCT2 upregulation in response to ethanol-induced neuronal injury is mediated by activation of JNK and p38 MAPKs and the NF-κB pathway; miR-125a-5p negatively regulates SVCT2 protein expression and is downregulated during binge drinking, and miR-125a-5p overexpression reduces SVCT2 levels and intracellular ascorbate, increasing neuronal vulnerability.\",\n      \"method\": \"Rat binge-drinking model; primary cortical neurons with SVCT2 siRNA; SVCT2 mRNA/protein quantification; MAPK and NF-κB phosphorylation Western blots; miR-125a-5p overexpression\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro models with siRNA KD, signaling pathway analysis, and miRNA regulation; single lab\",\n      \"pmids\": [\"27085842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Ascorbic acid increases SVCT2 levels at the plasma membrane via two distinct mechanisms: (1) an 'acute' response (~5–10 min) dependent on endocytic recycling (blocked by dominant-negative dynamin II, AP180, and Rab11); and (2) a 'post-acute' response (~30–60 min) dependent on SVCT2 trafficking from early secretory compartments (ER/Golgi), blocked by tunicamycin and brefeldin A and accelerated by the RUSH secretory system.\",\n      \"method\": \"RUSH system for synchronized ER-to-PM cargo trafficking; dominant-negative dynamin II, AP180, and Rab11 constructs; tunicamycin/brefeldin A treatment; surface biotinylation and ascorbate uptake assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal approaches including RUSH system, dominant-negative constructs, and pharmacological tools define two mechanistically distinct trafficking routes\",\n      \"pmids\": [\"29545069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SVCT2 promotes migration of neural stem/progenitor cells (NSPCs) from the subventricular zone toward ischemic lesions by upregulating CDC42, which promotes F-actin assembly; SVCT2 overexpression or ascorbate treatment increases NSPC migration in vivo and in vitro under oxygen-glucose deprivation.\",\n      \"method\": \"SVCT2 overexpression vectors in vivo and in vitro; OGD cell model; immunostaining for CDC42 and F-actin; NSPC migration counting in vivo\",\n      \"journal\": \"Frontiers in cellular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with defined cellular phenotype (migration) and mechanistic pathway (CDC42/F-actin); single lab\",\n      \"pmids\": [\"31607868\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SVCT2 is localized primarily in the cell membrane and endoplasmic reticulum (but not mitochondria) of cortical neurons; lentiviral SVCT2 overexpression increases neuronal branching and synaptic protein expression in primary cortical neurons, and this effect depends on vitamin C recycling between neurons and astrocytes (DHA produced by neurons is reduced back to ascorbate by glial GLUT1, and GLUT1 inhibition in glia abolishes branching both in vitro and in the cortex in situ).\",\n      \"method\": \"SVCT2 lentiviral overexpression; immunofluorescence colocalization with ER/mitochondrial markers; SVCT2+/- and SVCT2-Tg primary cultures; WZB117 GLUT1 inhibitor in vitro and in vivo; cortical neuron branching and synaptic protein quantification\",\n      \"journal\": \"Antioxidants (Basel, Switzerland)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function, genetic models (KO/Tg), and in vivo pharmacological inhibition with functional readouts; single lab\",\n      \"pmids\": [\"34573045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"p53 directly represses SVCT2 transcription by binding proximal (~-185 to -171 bp) and distal (~-1800 to -1787 bp) p53-responsive elements in the SVCT2 promoter; chromatin immunoprecipitation shows p53 recruits corepressor HDAC3, leading to deacetylation of histone Ac-H4 at the proximal promoter and transcriptional silencing.\",\n      \"method\": \"ChIP assays for p53 and HDAC3 binding and histone acetylation; promoter reporter deletion/mutation assays; p53 overexpression/knockdown\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with defined epigenetic readout (Ac-H4 deacetylation) and promoter mutagenesis; single lab\",\n      \"pmids\": [\"33580460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SVCT2 functions as a receptor-like transporter: upon ascorbate binding and transport, SVCT2 induces JAK2 phosphorylation; activated JAK2 then phosphorylates the SVCT2 C-terminus, recruiting and activating STAT2; JAK2 activation further promotes ascorbate functions via phosphorylation of PDK1, TET3, and histone H3 Tyr41.\",\n      \"method\": \"Co-immunoprecipitation of SVCT2–JAK2 interaction; phosphorylation assays; SVCT2 mutant constructs; JAK2 and STAT2 activation readouts\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP and phosphorylation assays reported from a single lab with limited methodological detail in the abstract; novel and not independently replicated\",\n      \"pmids\": [\"33484802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SVCT2-mediated ascorbate uptake in the medial prefrontal cortex supports DNA hydroxymethylation reprogramming via TET dioxygenases; chronic stress reduces SVCT2 expression and ascorbate in the mPFC, causing depressive-like behaviors through reduced TET-dependent demethylation, particularly at the S100A4 gene promoter, which in turn impairs ErbB4–BDNF signaling.\",\n      \"method\": \"Chronic stress mouse model; SVCT2 expression quantification; ascorbate HPLC; transcriptome and methylome sequencing; TET inhibition; ErbB4/BDNF pathway analysis\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — combined transcriptome + methylation sequencing with mechanistic pathway validation; single lab\",\n      \"pmids\": [\"36436457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SVCT2 is a novel sodium-dependent urate transporter in addition to its ascorbate transport function; cell-based assays in SVCT2-expressing mammalian cells demonstrated urate uptake, and ascorbate inhibits SVCT2-mediated urate transport with an IC₅₀ of ~36.59 µM, suggesting competitive transport at physiological ascorbate concentrations.\",\n      \"method\": \"SVCT2-expressing mammalian cell-based urate uptake assay; inhibition studies with ascorbate; confirmation in mouse Svct2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based functional transport assay with defined kinetics; replicated in mouse ortholog; single lab\",\n      \"pmids\": [\"37390985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Blue light irradiation specifically upregulates SVCT2 expression in melanoma cells via the NF-κB signaling pathway both in vitro and in vivo, increasing intracellular vitamin C and, together with Fe²⁺ generated by blue light, triggers ferroptosis.\",\n      \"method\": \"Blue light treatment of melanoma cells in vitro and mouse melanoma model in vivo; SVCT2 protein quantification; NF-κB inhibitor studies; ROS/ferroptosis markers\",\n      \"journal\": \"Biomaterials\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo evidence with defined signaling pathway (NF-κB); single lab, multiple methods\",\n      \"pmids\": [\"37276798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"UVB-induced ROS in human lens epithelial cells activates NF-κB signaling, which downregulates SVCT2 expression; reduced SVCT2 decreases ascorbate uptake, further increasing ROS and apoptosis; NF-κB or ROS inhibition restores SVCT2 and reduces apoptosis, defining an NF-κB/SVCT2/ascorbate regulatory axis.\",\n      \"method\": \"UVB treatment of HLECs; SVCT2 siRNA knockdown; NF-κB inhibitor (PDTC) and ROS inhibitor (NAC); ¹⁴C-ascorbate uptake assays; ROS, apoptosis, and Bcl-2/Bax quantification\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA KD with functional ascorbate uptake assay and pathway inhibitors; single lab\",\n      \"pmids\": [\"37246402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In late radial glia (lRG) cells in early postnatal cortex, SVCT2 is apically polarized; decreased SVCT2 (SVCT2+/- transgenic) accelerates lRG differentiation into astrocytes, whereas elevated SVCT2 expression (SVCT2-Tg) or ascorbate treatment maintains lRG in an undifferentiated state; in vivo SVCT2 overexpression in lRG generates migratory neuronal-marker-positive cells. The GSK3-β/AKT/mTORC2/PDK1 pathway is active in brains with high SVCT2/ascorbate levels.\",\n      \"method\": \"SVCT2+/- and SVCT2-Tg primary cultures and in vivo cortex; adenovirus-eGFP lineage tracing; immunofluorescence; GSK3-β/AKT/mTORC2 Western blots\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic gain- and loss-of-function models with multiple readouts; single lab\",\n      \"pmids\": [\"38180226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Estrogen receptor α (ERα) directly interacts with SVCT2 protein and stabilizes it; ERα knockdown reduces SVCT2 protein levels and ascorbate uptake. In ERα-deficient conditions, the E3 ubiquitin ligase XIAP ubiquitinates SVCT2 and targets it for proteasomal degradation; XIAP silencing rescues SVCT2 stability, defining an ERα–XIAP–SVCT2 regulatory axis.\",\n      \"method\": \"Co-immunoprecipitation of ERα–SVCT2; ERα and XIAP siRNA knockdown; proteasome inhibitor rescue; ¹⁴C-ascorbate uptake assays; ubiquitination assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for direct interaction, ubiquitination assay, and functional transport readout; single lab, multiple methods\",\n      \"pmids\": [\"40731045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SVCT2 overexpression in microglia before disease onset in 5xFAD Alzheimer's mice triggers redox reprogramming, generates a hybrid neuroprotective microglial phenotype co-expressing homeostatic and disease-associated markers, reduces amyloid plaque burden, and prevents synaptic/memory deficits; post-disease SVCT2 overexpression rescues synaptic plasticity and memory via changes in microglial secretory pathways, despite no effect on existing amyloid burden.\",\n      \"method\": \"Microglial-targeted SVCT2 overexpression in 5xFAD mice; primary microglial cultures from SVCT2-het and Tg mice; amyloid plaque quantification; synaptic and memory behavioral assays; microglial morphology and mRNA profiling\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gain-of-function with multiple orthogonal phenotypic readouts in genetic AD model; single lab\",\n      \"pmids\": [\"40907096\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC23A2/SVCT2 is a plasma membrane sodium-ascorbate cotransporter (2 Na⁺:1 ascorbate stoichiometry, Km ~50–70 µM) that mediates the primary active, concentrative uptake of ascorbic acid into metabolically active cells including neurons, glia, adrenal chromaffin cells, chondrocytes, Schwann cells, and immune cells; it localizes to the basolateral membrane of epithelial cells via an N-terminal targeting sequence and to the apical membrane of radial glia and tanycytes, with plasma membrane levels dynamically regulated by ascorbate-driven trafficking through both the early secretory pathway and endocytic recycling compartments; its transcription is controlled by cooperative YY1/Sp and NF-Y/USF complexes (with CpG methylation at the USF site providing cell-specific silencing) and is repressed by p53/HDAC3 and induced by NF-κB, AP-1, PKCβ/ERK, and redox signals; beyond transport, SVCT2 acts as a receptor-like transporter that activates JAK2/STAT2 signaling upon ascorbate binding, and XIAP-mediated ubiquitination (antagonized by ERα interaction) controls its protein stability; it also transports urate in a manner competitively inhibited by ascorbate, and its activity is essential for adrenal catecholamine synthesis, neuronal differentiation, osteogenic differentiation of bone marrow stromal cells, and modulation of the microglial neuroinflammatory response.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SLC23A2 (SVCT2) is a plasma-membrane sodium-dependent ascorbate cotransporter that mediates the concentrative, secondary-active uptake of vitamin C into metabolically active cells, with a Km of ~69 µM and a 2:1 Na⁺:ascorbate stoichiometry [#0]. It serves as the principal or sole active ascorbate transporter in diverse cell types including astrocytes [#3], chondrocytes—which concentrate ascorbate ~960-fold [#8]—Schwann cells [#15], bone marrow stromal cells [#19], and neurons [#11], and concentrates ascorbate in specialized brain cells such as apically polarized hypothalamic tanycytes [#7] and radial glia [#37]. In polarized epithelia SVCT2 is sorted to the basolateral membrane through a hierarchically dominant N-terminal basolateral targeting sequence, with a C-terminal element required for plasma-membrane incorporation [#1, #13]. Surface levels are dynamically tuned by ascorbate itself through a fast endocytic-recycling route and a slower ER/Golgi secretory route [#28]. Genetic loss of SVCT2 in mice depletes ascorbate in fetal cortex, placenta, and lung and is essential for life, impairing adrenal catecholamine synthesis via ascorbate-dependent dopamine β-hydroxylase and producing cortical hemorrhage and oxidative damage [#5, #14]. SVCT2 supports tissue-building programs including osteogenic differentiation of stromal cells [#19], neuronal branching and synaptic protein expression [#24, #30], and neural progenitor migration via CDC42/F-actin [#29]. Its transcription is governed by an exon 1b promoter driven by YY1 cooperating with Sp factors [#17] and a cell-specific exon 1a promoter controlled by NF-Y/USF complexes silenced by CpG methylation at the USF site [#18], with repression by p53/HDAC3 [#31] and redox-driven induction through NF-κB, AP-1, and PKCβ/MEK-ERK signaling [#10, #12]. Protein stability is set by an ERα–XIAP axis in which XIAP-mediated ubiquitination targets SVCT2 for degradation unless antagonized by ERα binding [#38]. Beyond ascorbate, SVCT2 also transports urate in a manner competitively inhibited by ascorbate [#34].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that hSVCT2 is itself a sodium-coupled ascorbate transporter defined the molecular identity and energetic basis of cellular vitamin C uptake.\",\n      \"evidence\": \"Functional expression of hSVCT2 cDNA in mammalian cells with radiolabeled ascorbate uptake and Na⁺ activation kinetics\",\n      \"pmids\": [\"10471399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of the transporter\", \"Substrate translocation mechanism not resolved at atomic level\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mapping SVCT2 expression in brain and demonstrating it sets steady-state intracellular ascorbate clarified which CNS cells depend on this transporter under baseline conditions.\",\n      \"evidence\": \"Northern blot, in situ hybridization, and functional uptake/mathematical modeling in neurons and cultured astrocytes\",\n      \"pmids\": [\"10841345\", \"11036152\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo astrocytic expression initially appeared culture-artifactual\", \"Did not address injury-induced expression\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Genetic knockout established that SVCT2 is physiologically essential, particularly for ascorbate-dependent adrenal catecholamine synthesis, moving it from a transporter to a required component of endocrine and developmental physiology.\",\n      \"evidence\": \"SVCT2 null mouse with HPLC catecholamine measurement, chromaffin cell ultrastructure, and tissue ascorbate quantification; MCAO ischemia ISH\",\n      \"pmids\": [\"12897061\", \"12887688\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking ascorbate to dopamine β-hydroxylase activity inferred rather than directly assayed\", \"Injury-induced astrocytic upregulation mechanism unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of the N-terminal basolateral targeting sequence answered how SVCT2 achieves polarized localization distinct from SVCT1.\",\n      \"evidence\": \"EGFP-tagged constructs with domain swaps and mutagenesis in MDCK/Caco-2 cells plus Transwell transport assays; tanycyte ISH/immunoEM/uptake\",\n      \"pmids\": [\"15993839\", \"19216494\", \"15625716\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking adaptors recognizing the BTS not identified\", \"Apical localization in tanycytes/radial glia uses a different determinant not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Dissecting the dual exon 1a/1b promoters and the PKCβ→MEK/ERK induction cascade established how SVCT2 expression is cell-type-specifically and inducibly controlled.\",\n      \"evidence\": \"Promoter deletion/reporter assays, EMSA supershifts, bisulfite methylation/demethylation, and isoform-selective inhibitor studies in THP-1 and multiple cell lines\",\n      \"pmids\": [\"19232538\", \"21335086\", \"21770893\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative usage of the two promoters across tissues not quantified\", \"Upstream signals selecting promoter usage incompletely mapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Loss-of-function in primary cells and feedback by intracellular ascorbate showed SVCT2 is the dominant active uptake route and is homeostatically autoregulated.\",\n      \"evidence\": \"siRNA/shRNA knockdown and phloretin inhibition in Schwann cells and BMSCs; ascorbate-synthesis-deficient SMP30/GNL KO hepatocytes; KO mouse oxidative-stress biomarkers\",\n      \"pmids\": [\"19672970\", \"20122894\", \"20541602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular sensor coupling intracellular ascorbate to expression not identified\", \"Tissue-specific feedback thresholds undefined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linking SVCT2 to osteogenic differentiation and redox-modulated expression connected the transporter to stem cell fate decisions.\",\n      \"evidence\": \"Lentiviral shRNA knockdown with osteogenic differentiation assays, kinetic transport characterization, and redox treatments in BMSCs; SVCT2-Tg gain-of-function mice\",\n      \"pmids\": [\"23089627\", \"22558179\", \"22763122\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ascorbate-dependent enzymatic step driving osteogenesis not pinpointed\", \"Cardiomyocyte data lack genetic confirmation\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery of a dominant-negative short isoform and gain-of-function neuronal effects revealed post-translational and morphogenic layers of SVCT2 regulation.\",\n      \"evidence\": \"FRET interaction of SVCT2sh with SVCT2wt plus uptake assays; lentiviral SVCT2-EYFP overexpression with MAP2/filopodia imaging and ERK phosphorylation in N2a cells\",\n      \"pmids\": [\"24947427\", \"26646539\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological abundance and regulation of the short isoform unknown\", \"Whether ERK activation is direct or downstream of ascorbate cofactor functions unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of miRNA repression (miR-141/miR-200a, later miR-125a-5p) added post-transcriptional control to SVCT2 regulation in differentiation and injury.\",\n      \"evidence\": \"3'-UTR luciferase reporters, miRNA mimics/inhibitors, and functional differentiation/uptake readouts in BMSCs and cortical neurons\",\n      \"pmids\": [\"25617715\", \"27085842\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo contribution of these miRNAs to SVCT2 levels not established\", \"Combinatorial miRNA regulation not modeled\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolving two distinct ascorbate-driven trafficking routes explained how surface SVCT2 abundance is dynamically tuned by substrate availability.\",\n      \"evidence\": \"RUSH synchronized ER-to-PM trafficking, dominant-negative dynamin II/AP180/Rab11, brefeldin A/tunicamycin, and surface biotinylation/uptake assays\",\n      \"pmids\": [\"29545069\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal transducing extracellular ascorbate to trafficking machinery not identified\", \"Cell-type generality of dual routes untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstration of p53/HDAC3 repression, ER localization, and vitamin C recycling-dependent neuronal effects integrated SVCT2 into epigenetic, organellar, and intercellular metabolic control.\",\n      \"evidence\": \"ChIP for p53/HDAC3 and histone acetylation with promoter mutagenesis; SVCT2 colocalization with ER markers; SVCT2 genetic models with GLUT1 inhibition in glia\",\n      \"pmids\": [\"33580460\", \"34573045\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional role of ER-localized SVCT2 not defined\", \"Direct downstream ascorbate-dependent enzymes in branching not pinpointed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Proposal of SVCT2 as a receptor-like transporter activating JAK2/STAT2 introduced a putative signaling function beyond transport.\",\n      \"evidence\": \"Co-immunoprecipitation of SVCT2–JAK2 and phosphorylation assays with mutant constructs\",\n      \"pmids\": [\"33484802\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single Co-IP/phosphorylation study not independently replicated\", \"Whether signaling is separable from transport activity unestablished\", \"Physiological relevance in vivo untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of urate as a second SVCT2 substrate competitively inhibited by ascorbate broadened the transporter's physiological substrate scope.\",\n      \"evidence\": \"SVCT2-expressing mammalian cell urate uptake assays with ascorbate inhibition kinetics, confirmed in mouse Svct2\",\n      \"pmids\": [\"37390985\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo contribution to urate handling not established\", \"Stoichiometry and physiological flux of urate transport unquantified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defining NF-κB-dependent bidirectional regulation of SVCT2 in melanoma and lens epithelium tied transporter levels to oxidative-stress outcomes including ferroptosis and apoptosis.\",\n      \"evidence\": \"Blue-light and UVB models with NF-κB/ROS inhibitors, siRNA knockdown, and ascorbate uptake/ferroptosis-apoptosis markers\",\n      \"pmids\": [\"37276798\", \"37246402\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Context determining whether NF-κB induces vs represses SVCT2 unresolved\", \"Direct NF-κB binding to SVCT2 promoter not demonstrated in these studies\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery of the ERα–XIAP axis controlling SVCT2 protein stability and microglial gain-of-function neuroprotection extended SVCT2 regulation to ubiquitin-mediated turnover and disease-modifying roles.\",\n      \"evidence\": \"Co-IP, XIAP/ERα siRNA, ubiquitination and proteasome-rescue assays; microglial-targeted SVCT2 overexpression in 5xFAD mice with plaque/synaptic/behavioral readouts\",\n      \"pmids\": [\"40731045\", \"40907096\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"XIAP ubiquitination sites on SVCT2 not mapped\", \"Mechanism by which microglial SVCT2 reprograms phenotype incompletely defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The transporter responsible for basolateral ascorbate efflux and the structural basis of SVCT2 substrate selection between ascorbate and urate remain unidentified.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"SLC23A2 does not mediate ascorbate efflux and the efflux carrier is unknown [#23]\", \"No atomic structure to explain dual ascorbate/urate transport\", \"Signaling vs transport functions not mechanistically separated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 8, 15, 34]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 34]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 13, 28, 30]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [28, 30]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 8, 34]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [14, 36]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [17, 18, 31]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"JAK2\", \"ESR1\", \"XIAP\", \"SLC23A2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}